Antiapoptotic properties of MALT1 protease are associated with redox homeostasis in ABC-DLBCL cells

被引:5
|
作者
Zhu, Leqing [1 ,2 ]
Tang, Fen [1 ,2 ]
Lei, Zhiwei [1 ,2 ,3 ]
Guo, Chengbin [1 ,2 ]
Song, Yueqi [1 ,2 ]
Huang, Junqing [4 ]
Xia, Xichun [1 ,2 ]
机构
[1] Jinan Univ, Affiliated Hosp 1, Biomed Translat Res Inst, 601 West Huangpu Ave, Guangzhou 510632, Guangdong, Peoples R China
[2] Jinan Univ, Sch Pharm, 601 West Huangpu Ave, Guangzhou 510632, Guangdong, Peoples R China
[3] Guangzhou Med Univ, Dept Basic Med Res, Affiliated Hosp 6, Qingyuan Peoples Hosp, Qingyuan, Guangdong, Peoples R China
[4] Jinan Univ, Sch Tradit Chinese Med, Formula Pattern Res Ctr, 601 West Huangpu Ave, Guangzhou 510632, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
ABC-DLBCL; apoptosis; GLS1; MALT1; protease; ROS; KAPPA-B ACTIVATION; GLUTAMINASE EXPRESSION; LYMPHOMA; CLEAVAGE; SURVIVAL; CARMA1; PHOSPHORYLATION; MITOCHONDRIA; DOXORUBICIN; STRATEGIES;
D O I
10.1002/mc.23122
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mucosa-associated lymphoid tissue lymphoma translocation protein-1 (MALT1) protease presents crucial antiapoptotic properties in activated B cell-like diffuse large B-cell lymphoma (ABC-DLBCL); however, the mechanism is unclear. Here, we reported that inhibition of MALT1 protease in ABC-DLBCL cells led to cell apoptosis, along with elevated mitochondrial reactive oxygen species production and a reduced oxygen consumption rate. These alterations induced by MALT1 protease inhibition were associated with reduced expression of glutaminase (GLS1) and glutathione levels. We further show that MALT1 protease was required for the activation and nuclear translocation of c-Jun, which functions as a transcription factor of the GLS1 gene by binding directly to its promoter region. Taken together, MALT1 protease maintained mitochondrial redox homeostasis and mitochondrial bioenergetics through the MALT1-c-Jun-GLS1-coupled metabolic pathway to defend against apoptosis in ABC-DLBCL cells, which raises exciting possibilities regarding targeting of the MALT1-c-Jun-GLS1 axis as a potential therapeutic strategy against ABC-DLBCL.
引用
收藏
页码:2340 / 2352
页数:13
相关论文
共 38 条
  • [1] Attacking MALT1 for ABC-DLBCL therapy
    Krappmann, Daniel
    ONCOTARGET, 2012, 3 (12) : 1489 - 1490
  • [2] Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL
    Nagel, Daniel
    Spranger, Stefani
    Vincendeau, Michelle
    Grau, Michael
    Raffegerst, Silke
    Kloo, Bernhard
    Hlahla, Daniela
    Neuenschwander, Martin
    von Kries, Jens Peter
    Hadian, Kamyar
    Doeken, Bernd
    Lenz, Peter
    Lenz, Georg
    Schendel, Dolores J.
    Krappmann, Daniel
    CANCER CELL, 2012, 22 (06) : 825 - 837
  • [3] Harnessing MALT1 inhibition for rational combinatorial therapy of ABC-DLBCL
    Fontan, Lorena
    Yang, Chenghua
    Kabaleeswaran, Venkataraman
    Volpon, Laurent
    Osborne, Michael
    Beltran, Elena
    Rosen, Monica
    Shaknovich, Rita
    Yang, Shao N.
    Gascoyne, Randy D.
    Cerchietti, Leandro
    Martinez-Climent, Jose A.
    Glickman, J. Fraser
    Borden, Katherine
    Wu, Hao
    Melnick, Ari
    CANCER RESEARCH, 2014, 74 (19)
  • [4] MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells
    Gehring, Torben
    Erdmann, Tabea
    Rahm, Marco
    Gras, Carina
    Flatley, Andrew
    O'Neill, Thomas J.
    Woods, Simone
    Meininger, Isabel
    Karayel, Ozge
    Kutzner, Kerstin
    Grau, Michael
    Shinohara, Hisaaki
    Lammens, Katja
    Feederle, Regina
    Hauck, Stefanie M.
    Lenz, Georg
    Krappmann, Daniel
    CELL REPORTS, 2019, 29 (04): : 873 - +
  • [5] MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo
    Fontan, Lorena
    Yang, Chenghua
    Kabaleeswaran, Venkataraman
    Volpon, Laurent
    Osborne, Michael J.
    Beltran, Elena
    Garcia, Monica
    Cerchietti, Leandro
    Shaknovich, Rita
    Yang, Shao Ning
    Fang, Fang
    Gascoyne, Randy D.
    Angel Martinez-Climent, Jose
    Glickman, J. Fraser
    Borden, Katherine
    Wu, Hao
    Melnick, Ari
    CANCER CELL, 2012, 22 (06) : 812 - 824
  • [6] Search for Novel MALT1 inhibitors by using ABC-DLBCL and GCB-DLBCL cell lines
    Son, Y.
    Park, C.
    Choi, S.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [7] Glutaminolysis Mediated by MALT1 Protease Activity Facilitates PD-L1 Expression on ABC-DLBCL Cells and Contributes to Their Immune Evasion
    Xia, Xichun
    Zhou, Wei
    Guo, Chengbin
    Fu, Zhen
    Zhu, Leqing
    Li, Peng
    Xu, Yan
    Zheng, Liangyan
    Zhang, Hua
    Shan, Changliang
    Gao, Yunfei
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [8] Pyrazolopyrimidines as novel selective allosteric MALT1 inhibitors with in vivo activity in ABC-DLBCL
    Weiss, Andreas
    Radimerski, Thomas
    Wyss, Daniel
    Andraos, Rita
    Buhles, Alexandra
    Sterker, Dario
    Quancard, Jean
    Pissot, Carole
    Simic, Oliver
    Bigaud, Marc
    Bornancin, Frederic
    Schlapbach, Achim
    Regnier, Catherine
    McSheehy, Paul
    Buchdunger, Elisabeth
    Wartmann, Markus
    Renatus, Martin
    Endres, Ralf
    Sellers, William
    Hofmann, Francesco
    CANCER RESEARCH, 2018, 78 (13)
  • [9] Identification of MALT1 feedback mechanisms enables rational design of potent antilymphoma regimens for ABC-DLBCL
    Fontan, Lorena
    Goldstein, Rebecca
    Casalena, Gabriella
    Durant, Matthew
    Teater, Matthew R.
    Wilson, Jimmy
    Phillip, Jude
    Xia, Min
    Shah, Shivem
    Us, Ilkay
    Shinglot, Himaly
    Singh, Ankur
    Inghirami, Giorgio
    Melnick, Ari
    BLOOD, 2021, 137 (06) : 788 - 800
  • [10] Substrate-mimetic covalent inhibitor of MALT1 is most effective against CARD11 mutant ABC-DLBCL
    Fontan, Lorena
    Scott, David
    Hatcher, John
    Qiao, Qi
    Us, Ilkay
    Casalena, Gabriella
    Bekkers, Mariette
    Philippar, Ulrike
    Durant, Matthew
    Chennamadhavuni, Spandan
    Wu, Hao
    Gray, Nathaniel
    Melnick, Ari
    CANCER RESEARCH, 2017, 77